Pulike shareholders approve governance overhaul, supervisory board eliminated

Pulike Biological Engineering Co., Ltd. held its second extraordinary general meeting of shareholders for 2025 on November 27, 2025. A total of 117 shareholders and proxies attended, representing 119,766,328 shares, or 35.0277% of the company's voting stock. All proposed resolutions passed without dissent.

Key approvals included the cancellation of the supervisory board and corresponding amendments to the company's articles of association. This resolution received 98.9891% of votes in favor from A-shareholders, with 118,555,628 votes. Additionally, shareholders approved revisions to several company governance documents, including the "Rules of Procedure for Shareholder Meetings," "Rules of Procedure for Board Meetings," and the "Independent Director Work System."

The meeting was convened by the company's board of directors and presided over by chairman Zhang Xuke. Beijing Deheng Law Firm witnessed the proceedings, confirming that the meeting's convening, procedures, and resolutions complied with relevant laws, regulations, and the company's articles of association.